LifeScience Biologics

Emmes Launches Cell and Gene Therapy Center

Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovatio...

 December 08, 2022 | News

Aarvik Therapeutics Announces a Global Novel Payload Agreement with NJ Bio, Inc.

Aarvik has an exclusive license to commercialize the novel proprietary payloads from NJ Bio, as well as any materials or products containing the payloads, ...

 December 08, 2022 | News

GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification

 GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, is partnering with Allozymes, a Singap...

 December 07, 2022 | News

Merck Gains Leading Perfusion Micro-Bioreactor with Erbi Biosystems Acquisition

Erbi’s differentiated 2 ml micro-bioreactor platform technology, Breez™, enables rapid lab testing for bioprocessing scale up Allows Merck t...

 December 07, 2022 | News

Fraunhofer IZI Selects Lonza’s MOD A-ES® Solution to Digitalize Manufacturing Operations

  The Fraunhofer Institute for Cell Therapy and Immunology (Fraunhofer IZI) has chosen Lonza’s MODA-ES® Manufacturing Execution System (M...

 December 06, 2022 | News

BRIM Biotechnology, Inc. raises $20 million in Series E funding round

Since the company’s inception in 2013, BRIM has successfully developed several platform technologies, including the regenerative peptide technology (...

 December 05, 2022 | News

Inventia enters into a distribution agreement for RASTRUM™ with SCRUM Inc in Japan

RASTRUM™, is a game-changing 3D cell culture platform that’s accelerating the quest to cure cancer and debilitating diseases. With applications...

 December 05, 2022 | News

Scipio bioscience announces single-cell Grant Program for four researchers valued up to US$30,000

With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, ...

 December 02, 2022 | News

Rocket Pharmaceuticals Completes Acquisition of Renovacor

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic th...

 December 02, 2022 | News

MGI Cements Its Presence and Contribution in Singapore's Genomics Landscape at ESMO Asia Congress 2022

At ESMO, MGI sets to showcase its MGISP-100 Automated Sample Preparation System and DNBSEQ-G99* Genetic Sequencer at Booth C209. Suitable for small and med...

 December 02, 2022 | News

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual ...

 December 01, 2022 | News

SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences

SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid tumors Preclinical efficacy and tolerabil...

 November 30, 2022 | News

Full-Life Technologies to Acquire Focus-X Therapeutics

Acquisition accelerates Full-Life's transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Dev...

 November 29, 2022 | News

BioPharma Dynamics provides cell media solutions for the Cell and Gene Therapy industry

BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a r...

 November 29, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close